Evidence map›Paper›PMID 24800720›Full record

ReviewAmerican journal of physical medicine & rehabilitation2014

Stem cells in the nervous system.

Angel R Maldonado-Soto, Derek H Oakley, Hynek Wichterle, Joel Stein, Fiona K Doetsch, Christopher E Henderson

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physical medicine & rehabilitation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.Journal of Alzheimer's disease : JAD · 2024
    Article
  7. Review
  8. Lactobacillus for ribosome peptide editing cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  9. Regenerative Medicine Therapy in Malaysia: An Update.Frontiers in bioengineering and biotechnology · 2022
    Review
  10. Article
  11. A Stem Cell Surge During Thyroid Regeneration.Frontiers in endocrinology · 2020
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Angel R Maldonado-SotoFrom the Columbia Stem Cell Initiative (ARM-S, DHO, HW, JS, FKD, CEH); Departments of Pathology and Cell Biology, Neurology and Neuroscience, Center for Motor Neuron Biology and Disease (ARM-S, DHO, HW, FKD, CEH); Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research (DHO, HW, CEH); and Department of Rehabilitation and Regenerative Medicine (ARM-S, JS, FKD, CEH), Columbia University Medical Center, New York, New York.
Derek H Oakley
Hynek Wichterle
Joel Stein
Fiona K Doetsch
Christopher E Henderson
Carbon Engineering (Canada) · CA

Funding

Prospective Purification of Adult Stem Cell AstrocytesR01NS074039 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHELANSKI, MICHAEL L · 2011 to 2015
$1.7M
Identification and regulation of quiescent stemcells in the adult brainF31NS079057 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MALDONADO, ANGEL RICARDO · 2012 to 2014
$142k
NINDS NIH HHS 5R01NS074039-03NINDS NIH HHS F31 NS079057NINDS NIH HHS F31NS079057NINDS NIH HHS R01 NS074039
6 · The paper itself

Abstract

Given their capacity to regenerate cells lost through injury or disease, stem cells offer new vistas into possible treatments for degenerative diseases and their underlying causes. As such, stem cell biology is emerging as a driving force behind many studies in regenerative medicine. This review focuses on the current understanding of the applications of stem cells in treating ailments of the human brain, with an emphasis on neurodegenerative diseases. Two types of neural stem cells are discussed: endogenous neural stem cells residing within the adult brain and pluripotent stem cells capable of forming neural cells in culture. Endogenous neural stem cells give rise to neurons throughout life, but they are restricted to specialized regions in the brain. Elucidating the molecular mechanisms regulating these cells is key in determining their therapeutic potential as well as finding mechanisms to activate dormant stem cells outside these specialized microdomains. In parallel, patient-derived stem cells can be used to generate neural cells in culture, providing new tools for disease modeling, drug testing, and cell-based therapies. Turning these technologies into viable treatments will require the integration of basic science with clinical skills in rehabilitation.

Indexed as

Amyotrophic Lateral SclerosisAnimalsCentral Nervous SystemCohort StudiesCombined Modality TherapyDisease Models, AnimalHumansNeurodegenerative DiseasesParkinson DiseasePhysical Therapy ModalitiesPrognosisQuality of LifeRecovery of FunctionRegenerative MedicineRisk AssessmentStem Cells

Identifiers

PMID24800720
PMCPMC4197112
OpenAlexW2318232070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.